“…Since fluorescence microscopy imaging can provide cellular resolution with several millimeters of penetration, it is a particularly attractive approach to detect tumor boundaries and tumor residuals. There are many nanoparticles such as quantum dots and nanoparticle conjugated or encapsulated fluorescence dye developed for tumor detection. − However, many existing molecular imaging probes nonspecifically accumulate within the healthy organs of the mononuclear phagocytic system (MPS), such as liver or spleen, which could compete with the tumor for the probes. , Small molecules such as indocyanine green (ICG) were also used for detection of primary and metastatic HCC. − However, ICG also could accumulate in noncancerous tissues in the liver, , which can compromise the STBR and result in false positives. In recent years, targeted fluorochromes such as folate modified FITC have been used in human ovarian cancer patients, and shown promising results; , however, similar results have not yet been reported for HCC.…”